AtriCure Reports First Quarter 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall St tumbles on tech selloff as concerns about hawkish Fed, AI spending mount
- SpaceX extends losses after $600 billion wipeout, tech stocks slide again
- Oil steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
AtriCure Inc. (ATRC) PT Raised to $81 at Needham & Company
April 28, 2021 6:20 AM EDTNeedham & Company analyst Mike Matson raised the price target on AtriCure Inc. (NASDAQ: ATRC) to $81.00 (from $74.00) while maintaining a Buy rating.
The analyst commented, "ATRC's 1Q21 revenue, adjusted EBITDA, and adjusted EPS all beat consensus. The impact from the pandemic eased during the... More
AtriCure (ATRC) Tops Q1 EPS by 5c, Revenues Beat; Offers FY21 EPS/Revenue Guidance Above Consensus
April 27, 2021 4:06 PM EDTAtriCure (NASDAQ: ATRC) reported Q1 EPS of ($0.32), $0.05 better than the analyst estimate of ($0.37). Revenue for the quarter came in at $59.3 million versus the consensus estimate of $56.06 million.
Our growth in the first quarter is a testament of our teams strong execution and unwavering dedication... More
